Syneron Medical (ELOS) Reports Q1 Adj-Loss of $0.23
Syneron Medical Ltd. (Nasdaq: ELOS) reports Q1 loss of $0.23, ex-items, versus the analyst estimate of ($0.16). Revenue for the quarter was $11.9 million, versus the consensus of $14.42 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
